Rodney Hochman Acquires 1,618 Shares of GE HealthCare Technologies (NASDAQ:GEHC) Stock

Posted by on May 15th, 2026

GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) Director Rodney Hochman purchased 1,618 shares of the company’s stock in a transaction on Tuesday, May 12th. The shares were bought at an average price of $62.03 per share, with a total value of $100,364.54. Following the completion of the transaction, the director owned 1,618 shares of the company’s stock, valued at approximately $100,364.54. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $62.67 on Friday. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The stock has a market cap of $28.51 billion, a PE ratio of 14.99, a P/E/G ratio of 1.39 and a beta of 0.74. The firm has a 50-day simple moving average of $69.95 and a two-hundred day simple moving average of $76.84. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. GE HealthCare Technologies’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on GEHC shares. BTIG Research dropped their price objective on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. HSBC dropped their price objective on shares of GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. Barclays dropped their price objective on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a report on Thursday, April 30th. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Finally, Rothschild & Co Redburn dropped their price objective on shares of GE HealthCare Technologies from $110.00 to $98.00 in a report on Thursday, April 30th. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $80.67.

Get Our Latest Stock Report on GE HealthCare Technologies

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in GEHC. Laurel Wealth Advisors LLC purchased a new position in GE HealthCare Technologies in the fourth quarter worth approximately $26,000. Optima Capital LLC purchased a new stake in shares of GE HealthCare Technologies during the 4th quarter worth approximately $27,000. Godfrey Financial Associates Inc. purchased a new stake in shares of GE HealthCare Technologies during the 4th quarter worth approximately $27,000. Montag A & Associates Inc. lifted its position in shares of GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after buying an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC lifted its position in shares of GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after buying an additional 262 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

(Get Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Featured Articles

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.